2021 - 2022 LEGISLATURE
October 4, 2021 - Introduced by Representatives Vos, Duchow, Magnafici,
Dittrich, Plumer, Edming, Penterman, Tittl, Allen, Summerfield, Schraa,
Rozar, Katsma, Loudenbeck, Sortwell, Callahan, Tusler, Gundrum,
Murphy, J. Rodriguez, Spiros, Knodl, Thiesfeldt and Wittke, cosponsored
by Senators Kapenga, Ballweg, Bradley, Felzkowski, Jagler, LeMahieu,
Marklein, Nass, Roth, Stroebel, Testin, Wanggaard and Bernier. Referred
to Committee on Health.
AB593,1,5 1An Act to amend 69.186 (1) (hm) and 69.186 (2) (intro.) and (a); and to create
269.186 (1) (gg) and (gm), 69.186 (1) (m), 253.10 (3) (c) 1. hr. and 253.10 (3) (d)
32m. of the statutes; relating to: informed consent regarding a certain
4abortion-inducing drug regimen and reporting requirements for induced
5abortions.
Analysis by the Legislative Reference Bureau
This bill requires certain information regarding an abortion-inducing drug
regimen to be provided to a woman that is planning to have an abortion induced by
the abortion-inducing drug regimen. The bill also adds to the information required
to be reported for induced abortions.
Informed consent
Under current law, a woman upon whom an abortion is to be performed or
induced must give voluntary and informed written consent to an abortion. Except
in a medical emergency, a woman's consent to an abortion is considered informed
only if, at least 24 hours before the abortion is performed or induced, the physician
or an assistant has, in person, orally provided the woman with certain information
and given to the woman certain written materials. If the pregnancy is the result of
sexual assault or incest, the 24-hour period, but not the provision of information,
may be waived or reduced under certain circumstances. The bill requires a
physician, as part of the information that must be provided, to inform the woman,

if she is considering or planning to have an abortion induced by an abortion-inducing
drug regimen that includes mifepristone, that the ingestion of the first drug in the
abortion-inducing drug regimen may not result in an immediate abortion and that,
if the woman changes her mind after ingesting the first drug, the woman may be able
to continue the pregnancy but time is of the essence and she should contact a
physician to discuss options or consult the information provided in the materials that
she is required to be given to locate a health care professional that can assist in
counteracting the effects of the drug. The bill requires the Department of Health
Services to include with the written materials that a woman considering an abortion
must be given materials that are designed to inform a woman about the possibilities
of continuing a pregnancy after ingesting an abortion-inducing drug, including
contact information for resources and health care professionals that assist women
in counteracting the effects of the drug and continuing their pregnancies.
Induced abortion reporting
The bill requires a hospital, clinic, or other facility in which an induced abortion
is performed to report additional information in its required annual report to DHS.
Under current law, the report must include, among other pieces of information, for
each patient, the state, and county if Wisconsin, of residence; certain demographic
information; the month and year in which the abortion was performed; the number
of weeks since the patient's last menstrual period; whether the abortion was
chemically or surgically induced or surgically induced following a failed chemical
abortion; any resulting complications; and certain information for abortions of an
unborn child capable of experiencing pain. The bill adds to the information required
in the report the number of previous induced abortions, if any; whether the induced
abortion was paid for by private health coverage, public assistance coverage, or
self-pay; and the reason for the induced abortion as selected from a list of reasons
specified in the bill. The bill also requires reporting of the specific method of a
chemical or surgical abortion and includes intrauterine instillation as a selection for
the method of abortion.
Under current law, DHS is required to collect the reported information in a
manner that ensures anonymity of the patient who obtained the abortion, the health
care provider who performed the abortion, and the hospital, clinic, or other facility
in which the abortion was performed. DHS is also required to publish annual
demographic summaries of the reported information except that which reveals the
identity of a patient, provider, or hospital, clinic, or other facility. The bill eliminates
the anonymity of the hospital, clinic, or other facility in which the abortion was
performed and requires that the annual summary by DHS include information
summarized by hospital, clinic, or other facility in which the abortion was performed.
The people of the state of Wisconsin, represented in senate and assembly, do
enact as follows:
AB593,1 1Section 1. 69.186 (1) (gg) and (gm) of the statutes are created to read:
AB593,3,1
169.186 (1) (gg) The number of previous induced abortions, if any.
AB593,3,32 (gm) Whether the induced abortion was paid for by private health coverage,
3public assistance coverage, or self-pay.
AB593,2 4Section 2. 69.186 (1) (hm) of the statutes is amended to read:
AB593,3,115 69.186 (1) (hm) Whether the abortion was a chemically induced abortion, and,
6if so, whether mifepristone, misoprostol, a combination of mifepristone and
7misoprostol, methotrexate, or another medication was used;
a surgical abortion and,
8if so, whether dilation and curettage, dilation and evacuation, hysterectomy or
9hysterotomy, or another surgical method was used;
or an intrauterine instillation
10and whether the abortion was
a surgical abortion following a failed or incomplete
11chemical abortion.
AB593,3 12Section 3. 69.186 (1) (m) of the statutes is created to read:
AB593,3,1413 69.186 (1) (m) The reason for the induced abortion as selected from any of the
14following reasons:
AB593,3,1515 1. The pregnancy was the result of rape.
AB593,3,1616 2. The pregnancy was the result of incest.
AB593,3,1717 3. Economic reasons.
AB593,3,1818 4. The woman does not want children or another child at this time.
AB593,3,1919 5. The woman's emotional health is at stake.
AB593,3,2020 6. The woman's physical health is at stake.
AB593,3,2221 7. The woman will suffer substantial and irreversible impairment of a major
22bodily function if the pregnancy continues.
AB593,3,2323 8. The pregnancy resulted in fetal anomalies.
AB593,3,2424 9. The reason is unknown or the woman refused to provide a reason.
AB593,4 25Section 4. 69.186 (2) (intro.) and (a) of the statutes are amended to read:
AB593,4,11
169.186 (2) (intro.) The department shall collect the information under sub. (1)
2in a manner which the department shall specify and which ensures the anonymity
3of a patient who receives an induced abortion, and a health care provider who
4provides an induced abortion and a hospital, clinic or other facility in which an
5induced abortion is performed
. The department shall publish annual demographic
6summaries of the information obtained under this section including information
7summarized by hospital, clinic, or other facility in which an induced abortion is
8performed
, except that the department may not disclose any information obtained
9under this section that reveals the identity of any patient, or health care provider or
10hospital, clinic or other facility
and shall ensure anonymity in all of the following
11ways:
AB593,4,1512 (a) The department may use information concerning the patient number under
13sub. (1) (b) or concerning the identity of a specific reporting hospital, clinic or other
14facility
for purposes of information collection only and may not reproduce or
15extrapolate this information for any purpose.
AB593,5 16Section 5. 253.10 (3) (c) 1. hr. of the statutes is created to read:
AB593,4,2417 253.10 (3) (c) 1. hr. If the woman is considering or planning to have an abortion
18induced by an abortion-inducing drug regimen that includes mifepristone, that the
19ingestion of the first drug in the abortion-inducing drug regimen may not result in
20an immediate abortion and that, if the woman changes her mind after ingesting the
21first drug, the woman may be able to continue the pregnancy but time is of the
22essence and she should contact a physician to discuss options or consult the
23information provided in the materials under par. (d) to locate a health care
24professional that can assist in counteracting the effects of the drug.
AB593,6 25Section 6. 253.10 (3) (d) 2m. of the statutes is created to read:
AB593,5,5
1253.10 (3) (d) 2m. Materials that are designed to inform a woman about the
2possibilities of continuing a pregnancy after ingesting an abortion-inducing drug.
3The materials shall include contact information for resources and health care
4professionals that assist women in counteracting the effects of the drug and
5continuing their pregnancies.
AB593,5,66 (End)
Loading...
Loading...